Zilidium
4 weeks ago
S-1 Does the forecast call for pain...
Pros: If PHIO demonstrates strong progress in its clinical trials, communicates a clear and effective use of proceeds, and generates positive clinical and financial milestones, the additional 5.9 million shares is a reasonable trade-off for long-term growth.
Cons: If there’s limited progress (no reason to believe there will be with the recent news) delays, or ambiguity about the company’s ability to monetize its pipeline, the market may view the dilution as detrimental, which will be bad, very, very bad indeed.
When will the warrants expire??
Series E Warrants: Exercisable until December 2029 @ $2.51
Series F Warrants: Exercisable until December 2029 @ 2.00
Series G, H, and I Warrants: Exercisable until January 2027 $3.00
Warrants must be exercised voluntarily, and holders typically do so when the market price exceeds the warrant exercise price.
This may get sloppy, so hold on.
Invest-in-America
1 month ago
PHIO: See ME, below, workin' on that $10.00, right now!!!
"PLEASE, Oh Lord, give me $10.00 even on PHIO today, & I'll donate 50% of my profits to THE STARVATION ARMY, and SAINT JUDE'S CHILDREN'S REFORMATORY!!"
Invest-in-America
1 month ago
PHIO: And the RED INK continues!! (But then, hopefully tomorrow they PR a proven Phase-3 CURE for every Cancer known to MANKIND!!!)
"Well, we're WAITING --- for your NEXT wonderful Cancer cure PR, oh great PHIO Company!!! And, will ya DUMP more shares to Market, the DAY thereafter???!!! We sincerely HOPE NOT!!!"